Literature DB >> 11397357

False lumen patency as a predictor of late outcome in aortic dissection.

Y Bernard1, H Zimmermann, S Chocron, J F Litzler, B Kastler, J P Etievent, N Meneveau, F Schiele, J P Bassand.   

Abstract

Aortic dissection (AD) is a disease with a high-risk of mortality. Late deaths are often related to complications in nonoperated aortic segments. Between 1984 and 1996, we retrospectively analyzed the data of 109 patients with acute AD (81 men and 28 women; average age 61 +/- 14 years). All imaging examinations were reviewed, and a magnetic resonance imaging examination was performed at the time of the study. Aortic diameters were measured on each aortic segment. Predictive factors of mortality were determined by Cox's proportional hazard model, in univariate and multivariate analyses, using BMDP statistical software. Follow-up was an average of 44 +/- 46 months (range 24 to 164). Actuarial survival rates were 52%, 46%, and 37% at 1, 5, and 10 years, respectively, for type A AD versus 76%, 72%, and 46% for type B AD. Predictors of late mortality were age >70 years and postoperative false lumen patency of the thoracic descending aorta (RR 3.4, 95% confidence intervals 1.20 to 9.8). Descending aorta diameter was larger when false lumen was patent (31 vs 44 mm; p = 0.02) in type A AD. Furthermore, patency was less frequent in operated type A AD when surgery had been extended to the aortic arch. Thus, patency of descending aorta false lumen is responsible for progressive aortic dilation. In type A AD, open distal repair makes it possible to check the aortic arch and replace it when necessary, decreases the false lumen patency rate, and improves late survival.

Entities:  

Mesh:

Year:  2001        PMID: 11397357     DOI: 10.1016/s0002-9149(01)01556-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  39 in total

1.  Endovascular treatment of thoracic aortic disease.

Authors:  R E Bell; J F Reidy
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

Review 2.  Acute aortic syndrome: pathology and therapeutic strategies.

Authors:  F Ahmad; N Cheshire; M Hamady
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

Review 3.  Diagnosis and management of patients with aortic dissection.

Authors:  Hüseyin Ince; Christoph A Nienaber
Journal:  Heart       Date:  2007-02       Impact factor: 5.994

Review 4.  Endovascular management of acute aortic dissection.

Authors:  Mamdouh Khayat; Kyle J Cooper; Minhaj S Khaja; Ripal Gandhi; Yolanda C Bryce; David M Williams
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

5.  Endovascular treatment of thoracic dissection.

Authors:  H Rousseau; O Cosin; B Marcheix; V Chabbert; M Midulla; C Dambrin; C Cron; B Leobon; C Conil; P Massabuau; P Otal; F Joffre
Journal:  Semin Intervent Radiol       Date:  2007-06       Impact factor: 1.513

Review 6.  Acute aortic syndromes.

Authors:  A M Booher; K A Eagle; E Bossone
Journal:  Herz       Date:  2011-09       Impact factor: 1.443

7.  Descending endograft for DeBakey type 1 aortic dissection: pro.

Authors:  Paolo Berretta; Marco Di Eusanio
Journal:  Ann Cardiothorac Surg       Date:  2016-05

8.  Editorial on the article entitled "the impact of intimal tear location and partial false lumen thrombosis in acute type b aortic dissection".

Authors:  Suk Jung Choo; Joon Bum Kim
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

9.  Open and closed distal anastomosis for acute type A aortic dissection repair.

Authors:  Pietro G Malvindi; Amit Modi; Szabolcs Miskolczi; Markku Kaarne; Theodore Velissaris; Clifford Barlow; Sunil K Ohri; Geoffrey Tsang; Steven Livesey
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-03-07

10.  Midterm results of aortic arch replacement in a stanford type a aortic dissection with an intimal tear in the aortic arch.

Authors:  Seong Ho Cho; Kiick Sung; Kay-Hyun Park; Ji-Hyuk Yang; Wook Sung Kim; Tae-Gook Jun; Young Tak Lee; Pyo Won Park
Journal:  Korean Circ J       Date:  2009-07-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.